Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ru Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107445989B discloses novel indole-based phosphine ligands offering high catalytic activity for C-S bond formation, ensuring cost-effective pharmaceutical intermediate manufacturing.
Patent CN102040564B reveals a safe, high-yield nucleophilic substitution route for 3-aminobenzo[d]isothiazole, offering significant cost reduction and supply chain stability for pharma manufacturing.
Novel Ru-catalyzed blue light method for 1,2,3-triazole quinoxalinones. High yield, mild conditions, reliable pharmaceutical intermediate supply chain solution.
Novel Ru-catalyzed transfer hydrogenation method for 3-acylpyrroles. High atom economy, scalable process for reliable pharmaceutical intermediate supply and cost reduction.
Novel indole-based phosphine ligands enable efficient C-S bond formation with high yields, offering cost-effective solutions for pharmaceutical manufacturing.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Discover scalable ruthenium-catalyzed N-acylpyrrole synthesis with 80% yield. Reduce costs and supply chain risks for pharma R&D and procurement with simplified industrial processes.
Discover a 95%+ yield, explosion-free synthesis of 2-trifluoromethyl dihydrobenzochromene. Eliminate heavy metal risks and scale to 100MT/yr with our CDMO expertise.
Eliminate expensive Pd/Rh catalysts and achieve 87% yield with ruthenium-catalyzed benzidine synthesis - ideal for scalable fungicide production.
Solve high-cost synthesis challenges with room-temperature, water-based production of polysubstituted distyryl indole derivatives. 99% yields, no toxic solvents, and simplified purification.
Discover how ruthenium-catalyzed cyclization eliminates heavy metal waste and reduces production costs for polyaromatic naphthalene derivatives in drug development and optoelectronics.
Solve high-temperature decarboxylation challenges with room-temperature gamma-cyanoolefin synthesis. Achieve 84% yield, 100% purity, and reduced energy costs for pharmaceutical intermediates.
83% yield, catalyst recyclability, and water-only byproduct in quinoline synthesis. Reduce solvent costs and EHS risks for pharma intermediates. Contact for CDMO solutions.
Solve high-cost catalysts and low yields in alpha-aryl carbonyl synthesis. New phosphorus ylide-based catalysts enable 90%+ yields with cheap chloroarenes, reducing supply chain risks for pharma R&D and production.